AZ's Top Cancer Drug In Trouble!

























AZ's cancer profile has always been in trouble and it is due to not aligning scientist rewards to successful commercialization. Over ten years ago AZ touted the extra rich cancer pipeline that they were to deliver. Where is it? One small launch since that time. I think for AZ the term should be pipedream not pipeline. Not expecting much to change after all these years. Please for the sake of cancer patients, surprise us. Poor AZ shareholders got bamboozled on the Pfizer deal. They will see.